Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018;50(3):93-99.
doi: 10.1007/s10353-018-0529-x. Epub 2018 May 4.

Optimal perioperative care in peri-hilar cholangiocarcinoma resection

Leonard M Quinn  1   2 , Declan F J Dunne  1 , Robert P Jones  1 , Graeme J Poston  1 , Hassan Z Malik  1 , Stephen W Fenwick  1
Affiliations

Optimal perioperative care in peri-hilar cholangiocarcinoma resection

Leonard M Quinn et al. Eur Surg. 2018.

Abstract

Surgical resection remains the only proven curative treatment for peri-hilar cholangiocarcinoma. Despite recent advances in liver surgery techniques and perioperative care, resection for peri-hilar cholangiocarcinoma remains associated with significant morbidity and mortality. Considerable variation in the perioperative management of these patients exists. Optimal perioperative management has the potential to deliver improved outcomes. This article seeks to summarize the evidence underpinning best practice in the perioperative care of patients undergoing resection of peri-hilar cholangiocarcinoma. The authors also seek to identify areas where research efforts and future clinical trials should be targeted.

Keywords: Cholangiocarcinoma; Enhanced Recovery; Peri-operative care; Pre-habilitation; Pre-operative fitness assessment.

PubMed Disclaimer

Conflict of interest statement

L.M. Quinn, D.F.J. Dunne, R.P. Jones, G.J. Poston, H.Z. Malik and S.W. Fenwick declare that they have no competing interests.

Similar articles

See all similar articles

Cited by

References

    1. Khan SA, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012;61:1657–1669. doi: 10.1136/gutjnl-2011-301748. - DOI - PubMed
    1. Kimura N, Young AL, Toyoki Y, Wyatt JI, Toogood GJ, Hidalgo E, Prasad KR, Kudo D, Ishido K, Hakamada K, Lodge JPA. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: outcome analysis and prognostic factors. Surgery. 2017;162:500–514. doi: 10.1016/j.surg.2017.03.017. - DOI - PubMed
    1. Gomez D, Patel PB, Lacasia-Purroy C, et al. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma. Eur J Surg Oncol. 2014;40(1):77–84. doi: 10.1016/j.ejso.2013.10.009. - DOI - PubMed
    1. Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258(1):129–140. doi: 10.1097/SLA.0b013e3182708b57. - DOI - PubMed
    1. DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245(5):755. doi: 10.1097/01.sla.0000251366.62632.d3. - DOI - PMC - PubMed

LinkOut - more resources